TABLE 1.
Continuous Distribution Score Component | Challenge | Proposed Solutions |
---|---|---|
| ||
Medical urgency | Unclear how to convert 6 therapy-based categories into continuous score | Develop novel multivariable model using post-2018 data and ensure that it is less susceptible to manipulation |
Post-transplantation survival | Difficult to predict post-transplantation outcomes using only candidate waitlist data | Update post-transplantation models and use donor-candidate interactions. Assign a small weight to this score component |
Patient access | Candidates with durable LVADs will have substantially lower medical urgency score | Add points for waiting time for patients with durable LVAD and those ineligible for LVAD therapy |
Candidate biology | Patients with blood type O and who are highly sensitized are at a disadvantage | Add points for candidates with blood type O and who are highly sensitized |
Placement efficiency | Evolving organ transport and preservation technologies make ischemic time effects difficult to estimate | Assign a very small weight to this score component |
LVAD = left ventricular assist device.